Nasdaq
$6.86▲ 9.06%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $13.2MShares out 1.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
12- 21h agoRegular26.10.23 23:318-KKey event#●●●#●●●#●●●
Bolt Biotherapeutics, Inc.
AI summary pendingBolt Biotherapeutics has acquired Prana Therapies and secured $120 million in private placement (PIPE) financing. Following the transaction, former Prana equityholders will hold approximately 51.7% of Bolt's outstanding common stock, and the company plans to seek stockholder approval for the conversion of Series D preferred stock and a potential reverse stock split at a ratio of 1:2 to 1:12.…more
$6.86+9.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.6After-hours26.10.07 05:078-KKey event
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics amended its lease agreement, involving an immediate $1.0 million payment and consent to a $1.5 million letter of credit draw. The company also agreed to an accelerated lease expiration date of December 31, 2027, and a $4.5 million termination payment contingent upon a future corporate transaction.…more
$6.86+9.06%vs prev closeView filingShare - 9.21After-hours26.09.22 07:054Ownership
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics executive Yonehiro Grant filed a Form 4 on September 21, 2026, reporting a change in beneficial ownership of securities as of September 16, 2026. This filing serves as a standard disclosure of insider stock holdings.…more
$6.86+9.06%vs prev closeView filingShare
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 22h agoRegular26.10.23 22:45
Trading Halt and Resumption Notice
Trading for a specific stock was temporarily halted and has since resumed following the release of news. Investors should review the latest company disclosures to inform their investment decisions.…more
$6.86+9.06%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 23h agoPre-market26.10.23 22:08
●●●●●●●● ●●●●● ●●●●●●
Bolt Biotherapeutics has acquired Prana Therapies and secured $120 million through a private placement to fund its clinical pipeline. The transaction results in significant shareholder dilution, with clinical data readouts for the lead program expected starting in 2027.…more
$6.86+9.06%vs prev close - 23h agoPre-market26.10.23 21:40
●●●●●●●● ●●●●● ●●●●●●
Trading for a stock has been temporarily halted in the U.S. market pending the release of significant news. Investors should remain cautious until the official announcement is made.…more
$6.86+9.06%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report